Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons N.J.D. Suthahar

Research interests

Dr. Navin Suthahar (MD, MSc, PhD) is an Assistant Professor in the Department of Cardiology at Erasmus MC, Rotterdam, the Netherlands. He is a Fellow of the European Society of Cardiology (ESC) and its Heart Failure Association (HFA). He serves as an Editorial Consultant for the Journal of the American College of Cardiology (JACC) and as Editor for BMC Medicine.

He obtained his MD in 2008, followed by PG diplomas in Respiratory Medicine and Cardiology, an MSc in Preventative Cardiology, and a PhD in Cardiology. During his doctoral training, he uncovered overlapping effects of obesity and sex on HF biomarker profiles. Specifically, he demonstrated that for NT-proBNP, male sex (not obesity) was strongly associated with lower levels in the general population, whereas obesity (not male sex) was strongly associated with lower levels in HF patients. He subsequently conducted a multicenter observational biomarker study at Massachusetts General Hospital, Harvard Medical School, USA.

With a full-time research focus, Dr. Suthahar now conducts studies on obesity-related HF, novel obesity / HFpEF biotargets, and sex-specific aspects of cardiometabolic disease using a multidisciplinary approach. He has published around 100 research items and holds a patent on circulating BMP10 for assessing congestion and pulmonary hypertension. He actively contributes to the cardiovascular community through the Netherlands Heart Institute (NLHI) and the European Society of Cardiology (ESC), helping shape national, European, and global research agendas for heart disease.

Publicaties

Associations of Serially Measured NT-proBNP With Incident Heart Failure With Reduced and Preserved Ejection Fraction

Cardiovascular-Kidney-Metabolic Medication Eligibility Across National Survey, Community-Based, and Ambulatory Healthcare Samples

Differential associations of cardiorenal-inflammatory markers with cardiac and cancer mortality in cancer survivors

Framingham risk score associates with incident cancer and heart failure

Redefining heart failure subtypes according to skeletal muscle mass

Relative fat mass as a predictor of incident stroke: evidence from the PREVEND cohort

Bone morphogenetic protein 10: clinical correlates and risk of incident atrial fibrillation

Circulating bmp10 (bone morphogenic protein 10) in the assessment of congestion and pulmonary hypertension

Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure

Peroxiredoxin-4, a marker of systemic oxidative stress, is associated with incident heart failure

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 4 – KwaliteitsonderwijsSDG 5 – GendergelijkheidSDG 17 - Partnerschap om de doelen te bereiken

Meer informatie over de Sustainable Development Goals.